+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cefotaxime"

Antibacterial Drugs Market Report 2024-2034 - Product Thumbnail Image

Antibacterial Drugs Market Report 2024-2034

  • Report
  • January 2024
  • 269 Pages
  • Global
From
From
Cephalosporin Markets in China - Product Thumbnail Image

Cephalosporin Markets in China

  • Report
  • October 2023
  • 270 Pages
  • China
From
Cephalosporin Industry Forecasts - China Focus - Product Thumbnail Image

Cephalosporin Industry Forecasts - China Focus

  • Report
  • October 2023
  • 135 Pages
  • China
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Cefotaxime is a third-generation cephalosporin antibiotic used to treat a wide range of bacterial infections. It is commonly used to treat infections of the respiratory tract, urinary tract, skin, and soft tissue. Cefotaxime is also used to treat meningitis, septicemia, and endocarditis. It is effective against both Gram-positive and Gram-negative bacteria. Cefotaxime is available in both intravenous and intramuscular forms. Cefotaxime is part of the larger market of antibiotics, which are used to treat bacterial infections. Antibiotics are a major component of modern medicine, and are used to treat a wide range of bacterial infections. The market for antibiotics is highly competitive, with many different companies offering a variety of products. Some of the companies in the Cefotaxime market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and AstraZeneca. Show Less Read more